Research programme: Alzheimer's disease therapies - NicOx
Alternative Names: NCX 2057; NCX 2213Latest Information Update: 16 May 2007
At a glance
- Originator NicOx
- Class Antidementias; Neuroprotectants
- Mechanism of Action Antioxidants; Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 23 Jul 2004 Preclinical trials in Alzheimer's disease in Italy (unspecified route)
- 23 Jul 2004 Data presented at the 9th International Conference on Alzheimer's Disease and Related Disorders (ICAD-2004) have been added to Pharmacodynamics section
- 17 Jul 2000 Preclinical development for Alzheimer's disease in France (Unknown route)